The store will not work correctly when cookies are disabled.
N-[(2S)-butan-2-yl]-2-(pyridin-4-yl)-1,7-naphthyridin-4-amine
ID: ALA4538809
PubChem CID: 137350503
Max Phase: Preclinical
Molecular Formula: C17H18N4
Molecular Weight: 278.36
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CC[C@H](C)Nc1cc(-c2ccncc2)nc2cnccc12
Standard InChI: InChI=1S/C17H18N4/c1-3-12(2)20-16-10-15(13-4-7-18-8-5-13)21-17-11-19-9-6-14(16)17/h4-12H,3H2,1-2H3,(H,20,21)/t12-/m0/s1
Standard InChI Key: FRSYLNRCCCXNRZ-LBPRGKRZSA-N
Molfile:
RDKit 2D
21 23 0 0 0 0 0 0 0 0999 V2000
17.3274 -7.7275 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.0135 -9.7581 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3202 -10.1626 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.5979 -9.7581 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5979 -8.9492 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3202 -8.5447 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0135 -8.9492 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9087 -8.5447 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1864 -8.9492 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1864 -9.7581 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.9087 -10.1626 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.7358 -10.1626 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.4292 -11.4049 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.7358 -11.0004 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1514 -11.0004 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.4292 -9.7581 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1507 -10.1552 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0386 -7.3252 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0458 -6.5080 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.7427 -7.7400 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.7571 -6.1057 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 7 1 0
2 7 2 0
5 8 1 0
8 9 2 0
9 10 1 0
11 10 2 0
4 11 1 0
2 12 1 0
16 12 2 0
13 15 1 0
14 13 2 0
12 14 1 0
17 15 2 0
16 17 1 0
6 1 1 0
1 18 1 0
18 19 1 0
18 20 1 6
19 21 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 278.36 | Molecular Weight (Monoisotopic): 278.1531 | AlogP: 3.90 | #Rotatable Bonds: 4 |
Polar Surface Area: 50.70 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 4.83 | CX LogP: 2.50 | CX LogD: 2.50 |
Aromatic Rings: 3 | Heavy Atoms: 21 | QED Weighted: 0.79 | Np Likeness Score: -0.95 |
References
1. (2018) 6-6 Fused Bicyclic Heteroaryl Compounds and their Use as LATS Inhibitors, |